Status:
COMPLETED
Lidocaine and Closed-Loop Anesthesia System
Lead Sponsor:
Hopital Foch
Conditions:
Anesthesia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The objective is to evaluate the sparing effect of Lidocaine on doses of propofol and remifentanil.
Eligibility Criteria
Inclusion
- patients ASA 1, 2 or 3 scheduled for a general anesthesia surgical procedure (abdominal surgery, urology, ENT major procedure) lasting between 1 and 3 hours
Exclusion
- age under 18 years
- simultaneous general and loco-regional anesthesia
- allergy to NSAID
- treatment with verapamil, ketamine or gabapentin
- patients receiving an opioid preoperatively
- severe hepatic insufficiency
- contra-indication to lidocaine
- contra-indication to propofol or to remifentanil
- history of central nervous system disease
- patients receiving a psychotropic treatment
- patients with a pace-maker
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT01154738
Start Date
January 1 2011
End Date
January 1 2015
Last Update
November 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Tenon
Paris, France, 75020